Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pars Gita Daru is a prominent Iranian pharmaceutical company dedicated to the supply, distribution, and manufacturing of specialized and high-tech medicinal products. Headquartered in Tehran, the company focuses on critical therapeutic areas including oncology, hematology, and neurology, ensuring that patients have access to advanced treatments for complex diseases. Pars Gita Daru operates as a strategic partner for international pharmaceutical manufacturers, facilitating the entry of innovative therapies into the Iranian market through its robust distribution network. In addition to distribution, the company is involved in local manufacturing and secondary packaging to enhance the domestic availability of essential drugs. Their portfolio features a variety of modalities, ranging from small molecules to sophisticated biologics and monoclonal antibodies. The company is recognized for its adherence to international quality standards and its role in maintaining the cold chain for sensitive medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pars Gita Daru.